Leewen Lin

Prior to AltruBio, Dr. Lin had been Senior Staff Fellow in Center of Biologics Evaluation and Research, US Food and Drug Administration, Director of Biotechnology Development Program of Yung-Shin Pharmaceutical, and Vice President of BioTrust International Corporation. Dr. Lin had been a member of the Intellectual Property Committee of Academia Sinica, and served as an advisor to the Biotechnology and Pharmaceutical Promotion Group, Ministry of Economic Affairs, Taiwan, on legal and regulatory affairs.

Dr. Lin received her Ph.D. in Biochemistry from North Carolina State University, and obtained her postdoctoral training in Genetics and Molecular Biology in Harvard Medical School and Massachusetts General Hospital. In addition, she received her L.L.M at Soochow University Law School, Taipei, Taiwan.